Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Implementation issues in disease management programs: a pharmaceutical company perspective.

R A Browne1

  • 1Eli Lilly and Company, Indianapolis, USA.

Medical Interface
|March 9, 1995
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of Components of Fusarium Head Blight Resistance in Soft Red Winter Wheat Germ Plasm Using a Detached Leaf Assay.

Plant disease·2019
Same author

The Day to Day Management of the Mentally Handicapped Child in Its Own Home.

Mental health (London)·2017
Same author

Population genetics and ecology of Artemia: Insights into parthenogenetic reproduction.

Trends in ecology & evolution·2011
Same author

Metabolic profile changes in the testes of mice with streptozotocin-induced type 1 diabetes mellitus.

International journal of andrology·2007
Same author

Designing naturalistic prospective studies of economic and effectiveness outcomes associated with novel antipsychotic therapies.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2006
Same author

Dialogue. Prescription for problems? Capitating mental health drugs--the great debate.

Behavioral healthcare tomorrow·1998
Same journal

Interfacing managed care and long-term care: understanding the issues.

Medical interface·1997
Same journal

HIPAA (Health Insurance Portability and Accountability Act) rules: federal and state enforcement.

Medical interface·1997
Same journal

Diabetes management: improving care in HMO and community settings.

Medical interface·1997
Same journal

Why don't we have "better" diabetes care?

Medical interface·1997
Same journal

Opportunities and challenges of electronic physician prescribing technology.

Medical interface·1997
Same journal

Electronic formulary control.

Medical interface·1997
See all related articles

A pharmaceutical company created a disease management subsidiary, offering a practical guide for establishing integrated disease management programs. This model can benefit other organizations entering the disease management field.

Area of Science:

  • Pharmaceutical Industry
  • Healthcare Management
  • Disease Management

Background:

  • Eli Lilly, a major pharmaceutical manufacturer, has launched a new subsidiary focused on disease management.
  • The author was instrumental in establishing this new venture.

Purpose of the Study:

  • To provide a practical guide for developing integrated disease management programs.
  • To share insights from the pharmaceutical company's experience in creating a disease management subsidiary.

Main Methods:

  • Case study of Eli Lilly's establishment of Integrated Disease Management, Inc.
  • Analysis of the company's experiences and strategic approach.

Main Results:

  • The establishment of Integrated Disease Management, Inc. by Eli Lilly.

Related Experiment Videos

  • Development of a replicable model for integrated disease management.

    • Conclusions:

    • The pharmaceutical company's approach to disease management is applicable to other organizations.
    • Insights gained can guide new ventures in the growing disease management sector.